(Q54131581)

25 May 2018

title

Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis. (English)

1 reference

25 May 2018

0 references

1 reference

T Jensen

1

1 reference

25 May 2018

S S Pedersen

series ordinal

2

1 reference

25 May 2018

N Høiby

series ordinal

3

1 reference

25 May 2018

C Koch

series ordinal

4

1 reference

25 May 2018

publication date

1 December 1987

1 reference

25 May 2018

European journal of clinical microbiology

published in

1 reference

25 May 2018

volume

6

1 reference

25 May 2018

issue

6

1 reference

25 May 2018

page(s)

618-622

1 reference

25 May 2018

In vitro and in vivo activity of DL-8280, a new oxazine derivative

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02013055

In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013055

Pharmacokinetics and pharmacodynamics of ciprofloxacin in cystic fibrosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013055

Antimicrobial activity of ciprofloxacin against Pseudomonas aeruginosa, Escherichia coli, and Staphylococcus aureus determined by the killing curve method: antibiotic comparisons and synergistic interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02013055

Ciprofloxacin-resistant Pseudomonas.

21 January 2018

1 reference

12 December 2020

Oral ciprofloxacin compared with conventional intravenous treatment for Pseudomonas aeruginosa infection in adults with cystic fibrosis

1 reference

12 December 2020

Resistance to ciprofloxacin.

1 reference

12 December 2020

Frequent antibiotic therapy improves survival of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection

1 reference

12 December 2020

Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?

1 reference

12 December 2020

Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis

1 reference

12 December 2020

Antibiotic Treatment of Haemophilus Influenzae and Haemophilus Parainfluenzae Infections in Patients with Cystic Fibrosis

1 reference

12 December 2020

Oral ciprofloxacin therapy of infections due to Pseudomonas aeruginosa

1 reference

12 December 2020

Ciprofloxacin in the treatment of acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Antibiotic treatment of Staphylococcus aureus infection in cystic fibrosis

1 reference

12 December 2020

Ciprofloxacin in cystic fibrosis

1 reference

12 December 2020

Hospital therapy improves exercise tolerance and lung function in cystic fibrosis

1 reference

12 December 2020

Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02013055

1 reference

25 May 2018

1 reference

25 May 2018